26 Publications (Page 1 of 2)
2012
Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli, Chandra S⋅Xiao, Jin⋅Parsons, Daniel L and Babu, R J
Drug development and industrial pharmacy, vol. 38, (no. 5), pp. 571-6, 2012/May. | Journal Article
2011
In vitro percutaneous absorption of genistein from topical gels through human skin.
Chadha, Gurkishan⋅Sathigari, Sateeshkumar⋅Parsons, Daniel L and Jayachandra Babu, R
Drug development and industrial pharmacy, vol. 37, (no. 5), pp. 498-505, 2011/May. | Journal Article
2010
Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli, Chandra S⋅Chadha, Gurkishan⋅Xiao, Jin⋅Parsons, Daniel L and Babu, R J
Journal of drug targeting, vol. 18, (no. 9), pp. 657-64, 2010/Nov. | Journal Article
2009
Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin.
Jayachandra Babu, R⋅Ravis, William R⋅Duran, Sue H⋅Schumacher, John⋅Cox, E⋅Stahl, R⋅Jones, K⋅Jean Lin, Y-J⋅Phillip Lee, Y-H⋅Parsons, Daniel L⋅Portman, E M and Brown, S C
Journal of veterinary pharmacology and therapeutics, vol. 32, (no. 4), pp. 388-92, 2009/Aug. | Journal Article
 
Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee, Y-H⋅Sathigari, Sateesh⋅Jean Lin, Y-J⋅Ravis, William R⋅Chadha, Gurkishan⋅Parsons, Daniel L⋅Rangari, Vijay K⋅Wright, Nydeia and Babu, R J
Drug development and industrial pharmacy, vol. 35, (no. 9), pp. 1113-20, 2009/Sep. | Journal Article
 
Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari, Sateeshkumar⋅Chadha, Gurkishan⋅Lee, Y-H P⋅Wright, Nydeia⋅Parsons, Daniel L⋅Rangari, Vijay K⋅Fasina, Oladiran O and Babu, R J
AAPS PharmSciTech, vol. 10, (no. 1), pp. 81-7, 2009. | Journal Article
2002
Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
Zhang, Lin⋅Parsons, Daniel L⋅Navarre, Christine and Kompella, Uday B
Journal of controlled release : official journal of the Controlled Release Society, vol. 85, (no. 1-3), pp. 73-81, 2002/Dec/13. | Journal Article
1991
Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute.
Shah, I G and Parsons, Daniel L
The Journal of pharmacy and pharmacology, vol. 43, (no. 11), pp. 790-3, 1991/Nov. | Journal Article
 
Perfluorochemical emulsion effect on human albumin binding of valproic acid.
Parsons, Daniel L⋅Ravis, W R and Huang, H C
Research communications in chemical pathology and pharmacology, vol. 73, (no. 2), pp. 245-8, 1991/Aug. | Journal Article
 
Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.
Parsons, Daniel L and Sathe, R S
Archives internationales de pharmacodynamie et de thérapie, vol. 310, pp. 5-12, 1991 Mar-Apr. | Journal Article
1990
Central and cardiovascular effects of the alcoholic extract of the leaves of Carica papaya.
Gupta, A.⋅Wambebe, C.O. and Parsons, Daniel L
International journal of crude drug research., vol. 28, (no. 4), pp. 257-266, 1990. | Journal Article
 
Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin.
Sathe, R S and Parsons, Daniel L
Archives internationales de pharmacodynamie et de thérapie, vol. 304, pp. 34-43, 1990 Mar-Apr. | Journal Article
1988
Effects of a perfluorochemical blood substitute on diazepam binding by human albumin.
Graben, R D and Parsons, Daniel L
The Journal of pharmacy and pharmacology, vol. 40, (no. 10), pp. 684-8, 1988/Oct. | Journal Article
1987
Effects of perfluorochemical emulsion components on human albumin binding of warfarin.
Parsons, Daniel L and Nadkarni, S R
Archives internationales de pharmacodynamie et de thérapie, vol. 288, (no. 2), pp. 165-74, 1987/Aug. | Journal Article
 
Limitations of fluorescence quenching data analysis in dantrolene binding by human albumin.
Kishnani, NS and Parsons, Daniel L
Pharmaceutica Acta Helvetiae, vol. 62, (no. 7), pp. 178-182, 1987. | Journal Article
 
Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin.
Parsons, Daniel L
Archives internationales de pharmacodynamie et de thérapie, vol. 286, (no. 1), pp. 23-30, 1987/Mar. | Journal Article
1986
Loss of propranolol during ultrafiltration in plasma protein binding studies.
Parsons, Daniel L and Fan, H F
Research communications in chemical pathology and pharmacology, vol. 54, (no. 3), pp. 405-8, 1986/Dec. | Journal Article
1985
Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.
Parsons, Daniel L⋅Ravis, William R and Clark, C. R
Archives internationales de pharmacodynamie et de thérapie, vol. 277, (no. 1), pp. 4-14, 1985/Sep. | Journal Article
1983
Furosemide binding by human albumin: comparison of two methods of fluorescence quenching analysis.
Parsons, Daniel L
Journal of pharmaceutical sciences, vol. 72, (no. 5), pp. 542-5, 1983/May. | Journal Article
1982
Fluorescence stability of human albumin solutions.
Parsons, Daniel L
Journal of pharmaceutical sciences, vol. 71, (no. 3), pp. 349-51, 1982/Mar. | Journal Article
1980
Analysis of fluorescence quenching data by the method of Levine.
Parsons, Daniel L
Clinical chemistry, vol. 26, (no. 13), pp. 1869-71, 1980/Dec. | Journal Article
 
A new method for the determination of the site binding constant of each species of a partially ionized drug.
Parsons, Daniel L and Vallner, J J
Acta pharmaceutica Suecica, vol. 17, (no. 1), pp. 12-30, 1980. | Journal Article
 
The effect of protein concentration on the binding of sulfamethoxypyridazine by human and bovine serum albumin.
Parsons, Daniel L
Archives internationales de pharmacodynamie et de thérapie, vol. 244, (no. 2), pp. 180-7, 1980/Apr. | Journal Article
1979
DRUG-MACROMOLECULE INTERACTIONS: COOPERATIVITY; DYNAMIC DIALYSIS; PH EFFECTS (Dissertation)
Parsons, Daniel L (1979).
 
Dynamic dialysis in drug-erythrocyte interactions.
Parsons, Daniel L and Vallner, J J
Journal of pharmaceutical sciences, vol. 68, (no. 5), pp. 546-51, 1979/May. | Journal Article